Cardiovascular Diseases

831 trials 335 recruiting

Filter these 831 trials by phase, country and sponsor.

Open in Search →

Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the t… Not authorised

2025-523374-17-01 Type 2 diabetes 6
MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction Not authorised

2023-507296-21-00 Acute Myocardial Infarction 5
A multicentre randomised study on percutaneous stellate ganglion block as first-line treatment in patients with electrical storm: the STAR 2… Not authorised

2024-520387-34-00 electrical storm 6
SAFEST Not authorised

2022-502059-79-00 Ischemic stroke or transient ischemic attack 6
Epinephrine versus Isoprenaline During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Not authorised

2024-516074-29-00 Cardiac arrest 5
A Masked, Multicentre, Placebo-controlled, Randomized Phase IIa Clinical Trial to investigate the safety and efficacy of ApTOLL in a populat… Not authorised

2023-503751-97-00 STEMI (ST Elevation Myocardial Infarct) 4
MK-0616-013 Not authorised

2022-502777-42-00 Hypercholesterolemia 5
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Not authorised

2022-502781-24-00 ASCVD - Atherosclerotic Cardiovascular Disease 11
AP01 Heart Failure (AHF) Study Not authorised

2023-507573-17-01 Acute Heart Failure 4
A Phase I-IIa Trial on the Safety and Preliminary Effectiveness of Intramyocardial Injection of Allogeneic Cardiac Atrial Stem Cells for the… Not authorised

2024-517031-51-00 Heart Failure 7
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
SGLT2 lnhibition in Hemodialysis (DAPA-HD) Pending

2024-518591-31-00 Chronic Kidney Disease 4
CARDIOPROTECTIVE-NEPHROPROTECTIVE EFFECTS OF SEVOFLURANE IN COMPARISON WITH PROPOFOL IN DOUBLE VALVE SURGERY. USE OF SEVOFLURANE AS A PILLAR… Pending

2025-520812-33-00 To evaluate the effects of sevoflurane administration i 10
HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY) Pending

2024-519107-10-00 transthyretin cardiac amyloidosis 6
Colchicine to inhibit atherosclerosis in patients with cancer receiving immune therapy Pending

2024-518100-45-00 Atherosclerosis 5
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending

2024-520218-23-00 Pulmonary Arterial Hypertension 10
A Phase 1, open label, randomised, 2-period, 2 sequence, 7-days repeat-dosing, crossover oral pharmacokinetic trial comparing multiple dosin… Pending

2025-524883-39-00 Cardiopulmonary diseases with contributions of thrombos 3
The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study Pending

2024-516279-34-00 Pulmonary Hypertension 6
ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Pending

2025-521478-32-00 PEDIATRIC ACUTE MYOCARDITIS 5
Early use of dapagliflozin in patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 Dapagliflozin… Pending

2025-521481-10-00 Acute Myocardial Infarction 6
Self-Assessment Method for Statin side-effects Or Nocebo 2 Pending

2025-524955-30-01 Cardiovascular diseases 11
Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ischemic heart disease Pending

2024-518640-20-00 Chronic ischemic heart disease 4
Phase 1b Study of VERVE-201 in Patients with Refractory Hyperlipidemia Pending

2025-522617-39-00 Refractory hyperlipidemia 1
Extension Study of ACT-EARLY Pending

2024-513676-18-00 Transthyretin Amyloidosis 5